BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge M. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer. 2011;129:1661-1670. [PMID: 21128279 DOI: 10.1002/ijc.25823] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Bansal A, Fitzgerald RC. Biomarkers in Barrett's Esophagus: Role in Diagnosis, Risk Stratification, and Prediction of Response to Therapy. Gastroenterol Clin North Am 2015;44:373-90. [PMID: 26021200 DOI: 10.1016/j.gtc.2015.02.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Grady WM, Yu M, Markowitz SD, Chak A. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers. Cancer Epidemiol Biomarkers Prev 2020;29:2486-94. [PMID: 33093162 DOI: 10.1158/1055-9965.EPI-20-0223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cui R, Kim T, Fassan M, Meng W, Sun HL, Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, Liang G, Zhang YK, Chakravarti A, Croce CM. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget 2015;6:21802-15. [PMID: 26307684 DOI: 10.18632/oncotarget.5224] [Cited by in Crossref: 36] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
4 Gao Y, Liu M, Shi S, Sun Y, Li M, Zhang M, Sheng Z, Zhang J, Tian J; Cancer Biomarker Assessment Working Group. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy. Clin Exp Med 2020;20:97-108. [DOI: 10.1007/s10238-019-00598-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Pusung M, Zeki S, Fitzgerald R. Genomics of Esophageal Cancer and Biomarkers for Early Detection. Adv Exp Med Biol 2016;908:237-63. [PMID: 27573775 DOI: 10.1007/978-3-319-41388-4_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X. Molecular mechanisms of Barrett's esophagus. Dig Dis Sci 2011;56:3405-20. [PMID: 21984436 DOI: 10.1007/s10620-011-1885-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chen Y, Du M, Chen W, Zhu L, Wu C, Zhang Z, Wang M, Chu H, Gu D, Chen J. Polymorphism rs2682818 in miR-618 is associated with colorectal cancer susceptibility in a Han Chinese population. Cancer Med 2018;7:1194-200. [PMID: 29533012 DOI: 10.1002/cam4.1409] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Fassan M, Pizzi M, Realdon S, Balistreri M, Guzzardo V, Zagonel V, Castoro C, Mastracci L, Farinati F, Nitti D, Zaninotto G, Rugge M. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Human Pathology 2013;44:1804-10. [DOI: 10.1016/j.humpath.2013.01.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
9 Fassan M, Realdon S, Pizzi M, Balistreri M, Battaglia G, Zaninotto G, Ancona E, Rugge M. Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Dis Esophagus. 2012;25:263-268. [PMID: 21883657 DOI: 10.1111/j.1442-2050.2011.01236.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
10 Zheng Y, Lu T, Xie X, He Q, Lu L, Zhong W. miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children. Biosci Rep 2020;40:BSR20193989. [PMID: 32364585 DOI: 10.1042/BSR20193989] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch. 2013;462:57-63. [PMID: 23224068 DOI: 10.1007/s00428-012-1345-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
12 Fu A, Hoffman AE, Liu R, Jacobs DI, Zheng T, Zhu Y. Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis. Epigenetics 2014;9:730-7. [PMID: 24503492 DOI: 10.4161/epi.27996] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
13 Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol 2015;98:411-8. [PMID: 25746664 DOI: 10.1016/j.yexmp.2015.03.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
14 Fassina A, Cappellesso R, Fassan M. Classification of Non-small Cell Lung Carcinoma in Transthoracic Needle Specimens Using MicroRNA Expression Profiling. Chest 2011;140:1305-11. [DOI: 10.1378/chest.11-0708] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
15 Wallmark B. Omeprazole: mode of action and effect on acid secretion in animals. Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:101-106. [PMID: 2657278 DOI: 10.1007/s10620-015-3959-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
16 Rugge M. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication. Gastroenterology Clinics of North America 2015;44:609-24. [DOI: 10.1016/j.gtc.2015.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kailasam A, Mittal SK, Agrawal DK. Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma. Clin Transl Sci 2015;8:394-402. [PMID: 25388215 DOI: 10.1111/cts.12242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
18 Xi S, Inchauste S, Guo H, Shan J, Xiao Z, Xu H, Miettenen M, Zhang MR, Hong JA, Raiji MT, Altorki NK, Casson AG, Beer DG, Robles AI, Bowman ED, Harris CC, Steinberg SM, Schrump DS. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene 2015;34:5548-59. [PMID: 25703328 DOI: 10.1038/onc.2015.10] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
19 David S, Meltzer SJ. MicroRNA involvement in esophageal carcinogenesis. Curr Opin Pharmacol. 2011;11:612-616. [PMID: 21992930 DOI: 10.1016/j.coph.2011.09.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
20 Gao QY, Fang JY. Early esophageal cancer screening in China. Best Pract Res Clin Gastroenterol 2015;29:885-93. [PMID: 26651250 DOI: 10.1016/j.bpg.2015.09.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
21 Fassan M, Mastracci L, Grillo F, Zagonel V, Bruno S, Battaglia G, Pitto F, Nitti D, Celiento T, Zaninotto G. Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology. 2012;61:769-776. [PMID: 22882541 DOI: 10.1111/j.1365-2559.2012.04272.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
22 Lv J, Liu J, Guo L, Zhang J, Cheng Y, Chen C, Zhao H, Wang J. Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus. Cell Cycle 2018;17:792-800. [PMID: 29417867 DOI: 10.1080/15384101.2018.1431597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011; 17(48): 5231-5239 [PMID: 22219591 DOI: 10.3748/wjg.v17.i48.5231] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
24 Brücher BL, Li Y, Schnabel P, Daumer M, Wallace TJ, Kube R, Zilberstein B, Steele S, Voskuil JL, Jamall IS. Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers. Clin Transl Med 2016;5:13. [PMID: 27053248 DOI: 10.1186/s40169-016-0093-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Clark RJ, Craig MP, Agrawal S, Kadakia M. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review. Oncotarget 2018;9:8179-96. [PMID: 29487725 DOI: 10.18632/oncotarget.24145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Song S, Ajani JA. The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2013;10:109-18. [PMID: 23165235 DOI: 10.1038/nrgastro.2012.210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
27 Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P, Svoboda M, Hajduch M, Ehrmann J. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Carcinogenesis. 2015;36:521-527. [PMID: 25784377 DOI: 10.1093/carcin/bgv023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
28 Feng X, Ji D, Liang C, Fan S. Does miR-618 rs2682818 variant affect cancer susceptibility? Evidence from 10 case-control studies. Biosci Rep 2019;39:BSR20190741. [PMID: 31383788 DOI: 10.1042/BSR20190741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res. 2013;19:4067-4078. [PMID: 23757351 DOI: 10.1158/1078-0432.ccr-13-0601] [Cited by in Crossref: 59] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
30 Mian C, Pennelli G, Fassan M, Balistreri M, Barollo S, Cavedon E, Galuppini F, Pizzi M, Vianello F, Pelizzo MR, Girelli ME, Rugge M, Opocher G. MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid 2012;22:890-6. [PMID: 22747440 DOI: 10.1089/thy.2012.0045] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 8.4] [Reference Citation Analysis]
31 Bus P, Siersema PD, Verbeek RE, van Baal JW. Upregulation of miRNA-143, -145, -192, and -194 in esophageal epithelial cells upon acidic bile salt stimulation. Dis Esophagus 2014;27:591-600. [PMID: 24006894 DOI: 10.1111/dote.12112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
32 Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One. 2013;8:e64463. [PMID: 23724052 DOI: 10.1371/journal.pone.0064463] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
33 Fassan M, Baffa R, Kiss A. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 2013;27:159-169. [PMID: 23809238 DOI: 10.1016/j.bpg.2013.03.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
34 Zhang SQ, Yang Z, Cai XL, Zhao M, Sun MM, Li J, Feng GX, Feng JY, Ye LH, Niu JQ, Zhang XD. miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacol Sin 2017;38:1161-70. [PMID: 28603285 DOI: 10.1038/aps.2017.62] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
35 Xu J, Yin Z, Yang L, Wu F, Fan J, Huang Q, Jin Y, Yang G. Evidence that dysplasia related microRNAs in Barrett's esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma. Aging (Albany NY) 2020;12:17062-78. [PMID: 32903213 DOI: 10.18632/aging.103634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Morales S, Gulppi F, Gonzalez-Hormazabal P, Fernandez-Ramires R, Bravo T, Reyes JM, Gomez F, Waugh E, Jara L. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population. BMC Genet 2016;17:109. [PMID: 27421647 DOI: 10.1186/s12863-016-0415-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
37 Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD. MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol. 2013;4:e34. [PMID: 23677165 DOI: 10.1038/ctg.2013.5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
38 Fassina A, Marino F, Siri M, Zambello R, Ventura L, Fassan M, Simonato F, Cappellesso R. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest. 2012;92:1574-1582. [PMID: 22964854 DOI: 10.1038/labinvest.2012.129] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
39 Bansal A, Lee IH, Hong X, Mathur SC, Tawfik O, Rastogi A, Buttar N, Visvanathan M, Sharma P, Christenson LK. Discovery and validation of Barrett's esophagus microRNA transcriptome by next generation sequencing. PLoS One 2013;8:e54240. [PMID: 23372692 DOI: 10.1371/journal.pone.0054240] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
40 Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, Fassan M. Epithelial–mesenchymal transition in malignant mesothelioma. Mod Pathol 2012;25:86-99. [DOI: 10.1038/modpathol.2011.144] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 8.7] [Reference Citation Analysis]
41 Cui Z, Liu JX, Gao YL, Zheng CH, Wang J. RCMF: a robust collaborative matrix factorization method to predict miRNA-disease associations. BMC Bioinformatics 2019;20:686. [PMID: 31874608 DOI: 10.1186/s12859-019-3260-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Fassan M, Dall'Olmo L, Galasso M, Braconi C, Pizzi M, Realdon S, Volinia S, Valeri N, Gasparini P, Baffa R, Souza RF, Vicentini C, D'Angelo E, Bornschein J, Nuovo GJ, Zaninotto G, Croce CM, Rugge M. Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget 2014;5:7162-71. [PMID: 25216530 DOI: 10.18632/oncotarget.2249] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
43 Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, Rugge M. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch. 2011;458:413-419. [PMID: 21279518 DOI: 10.1007/s00428-011-1046-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
44 Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One 2015;10:e0128617. [PMID: 26039359 DOI: 10.1371/journal.pone.0128617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
45 Rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S, De Bernard M, Betterle C, Cappellesso R, Pennelli G. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther. 2012;35:1460-1466. [PMID: 22519568 DOI: 10.1111/j.1365-2036.2012.05101.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
46 Liu L, Wang S, Cao X, Liu J. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis. Tumor Biol 2014;35:12245-53. [DOI: 10.1007/s13277-014-2533-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
47 Link A, Goel A. MicroRNA in gastrointestinal cancer: a step closer to reality. Adv Clin Chem. 2013;62:221-268. [PMID: 24772669 DOI: 10.1016/b978-0-12-800096-0.00006-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
48 Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev 2016;25:429-37. [PMID: 26604271 DOI: 10.1158/1055-9965.EPI-15-0161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
49 Matsuzaki J, Suzuki H. Circulating microRNAs as potential biomarkers to detect transformation of Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open Gastroenterol 2017;4:e000160. [PMID: 29177063 DOI: 10.1136/bmjgast-2017-000160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
50 Matsuzaki J, Suzuki H. MicroRNAs in Barrett's esophagus: future prospects. Front Genet 2014;5:69. [PMID: 24765103 DOI: 10.3389/fgene.2014.00069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
51 Matsuzaki J, Suzuki H, Tsugawa H, Watanabe M, Hossain S, Arai E, Saito Y, Sekine S, Akaike T, Kanai Y. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology. 2013;145:1300-1311. [PMID: 23933602 DOI: 10.1053/j.gastro.2013.08.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
52 Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig Dis Sci. 2013;58:3178-3188. [PMID: 23925817 DOI: 10.1007/s10620-013-2806-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
53 Revilla-Nuin B, Parrilla P, Lozano JJ, de Haro LF, Ortiz A, Martínez C, Munitiz V, de Angulo DR, Bermejo J, Molina J, Cayuela ML, Yélamos J. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg 2013;257:886-93. [PMID: 23059500 DOI: 10.1097/SLA.0b013e31826ddba6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
54 Jankowski M, Wani S. Diagnostic and Management Implications of Basic Science Advances in Barrett’s Esophagus. Curr Treat Options Gastro 2015;13:16-29. [DOI: 10.1007/s11938-014-0040-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
55 Estores D, Velanovich V. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg. 2013;50:192-226. [PMID: 23601575 DOI: 10.1067/j.cpsurg.2013.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
56 Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, Canto M, Wang JS, Maitra A, Willis J, Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A, Guda K. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer. 2012;51:473-479. [PMID: 22302717 DOI: 10.1002/gcc.21934] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
57 Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World J Gastroenterol 2017; 23(30): 5508-5518 [PMID: 28852310 DOI: 10.3748/wjg.v23.i30.5508] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
58 Xie S, Wang Y, Liu H, Wang M, Yu H, Qiao Y, Li F, Xie X, Zhang J. Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis. Biomarkers in Medicine 2016;10:661-74. [DOI: 10.2217/bmm-2015-0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog 2011;10:34. [PMID: 22279419 DOI: 10.4103/1477-3163.91110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
60 Plum PS, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Novel diagnostic and prognostic biomarkers in esophageal cancer. Expert Opin Med Diagn 2013;7:557-71. [PMID: 24093836 DOI: 10.1517/17530059.2013.843526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
61 Gil-Gómez G, Fassan M, Nonell L, Garrido M, Climent M, Anglada R, Iglesias M, Guzzardo V, Borga C, Grande L, de Bolós C, Pera M. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus. Dis Esophagus 2021;34:doab005. [PMID: 33558874 DOI: 10.1093/dote/doab005] [Reference Citation Analysis]
62 Bansal A, Gupta V, Wang K. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus. J Cell Biochem. 2016;117:1288-1295. [PMID: 26808728 DOI: 10.1002/jcb.25497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
63 Saraggi D, Galuppini F, Fanelli GN, Remo A, Urso ED, Bao RQ, Bacchin D, Guzzardo V, Luchini C, Braconi C, Farinati F, Rugge M, Fassan M. MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions. Pathology - Research and Practice 2018;214:835-9. [DOI: 10.1016/j.prp.2018.04.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
64 Bus P, Kestens C, Ten Kate FJ, Peters W, Drenth JP, Roodhart JM, Siersema PD, van Baal JW. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol. 2016;51:560-570. [PMID: 26585599 DOI: 10.1007/s00535-015-1133-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X, Gao Z, Xin J, Zhou S, Zhou Z. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett. 2014;342:121-129. [PMID: 24001611 DOI: 10.1016/j.canlet.2013.08.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
66 Boudhraa Z, Carmona E, Provencher D, Mes-Masson AM. Ran GTPase: A Key Player in Tumor Progression and Metastasis. Front Cell Dev Biol 2020;8:345. [PMID: 32528950 DOI: 10.3389/fcell.2020.00345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
67 Pizzi M, Fassan M, Realdon S, Balistreri M, Battaglia G, Giacometti C, Zaninotto G, Zagonel V, De Boni M, Rugge M. Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. Hum Pathol. 2012;43:1839-1844. [PMID: 22521076 DOI: 10.1016/j.humpath.2012.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
68 Lv J, Zhao HP, Dai K, Cheng Y, Zhang J, Guo L. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol 2020; 26(22): 2889-2901 [PMID: 32587437 DOI: 10.3748/wjg.v26.i22.2889] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
69 Galuppini F, Fassan M, Bertazza L, Barollo S, Cascione L, Watutantrige-Fernando S, Lazzarin V, Simonato P, Vianello F, Rugge M, Mian C, Pennelli G. Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma. Cancer Manag Res 2019;11:7845-55. [PMID: 31692513 DOI: 10.2147/CMAR.S194344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
70 Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG, Yang K. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014;47:277-286. [PMID: 24909356 DOI: 10.1111/cpr.12109] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
71 Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23:512-521. [PMID: 24013023 DOI: 10.1016/j.semcancer.2013.08.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
72 Xin H, Li X, Yang B, Zhang L, Han Z, Han C. Blood-based multiple-microRNA assay displays a better diagnostic performance than single-microRNA assay in the diagnosis of breast tumor. Tumour Biol 2014;35:12635-43. [PMID: 25213696 DOI: 10.1007/s13277-014-2587-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Fang Y, Chen X, Bajpai M, Verma A, Das KM, Souza RF, Garman KS, Donohoe CL, O’Farrell NJ, Reynolds JV. Cellular origins and molecular mechanisms of Barrett’s esophagus and esophageal adenocarcinoma. Ann N Y Acad Sci. 2013;1300:187-199. [PMID: 24117642 DOI: 10.1111/nyas.12249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
74 Zahm AM, Menard-Katcher C, Benitez AJ, Tsoucas DM, Le Guen CL, Hand NJ, Friedman JR. Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs. Am J Physiol Gastrointest Liver Physiol 2014;307:G803-12. [PMID: 25147232 DOI: 10.1152/ajpgi.00121.2014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
75 Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013;6:196-205. [PMID: 23466817 DOI: 10.1158/1940-6207.capr-12-0276] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
76 Fassan M, Saraggi D, Balsamo L, Cascione L, Castoro C, Coati I, De Bernard M, Farinati F, Guzzardo V, Valeri N. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget. 2016;7:4915-4924. [PMID: 26701848 DOI: 10.18632/oncotarget.6642] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
77 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
78 Li SQ, Chen FJ, Cao XF. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment. Dis Esophagus 2013;26:288-98. [PMID: 22458808 DOI: 10.1111/j.1442-2050.2012.01346.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
79 Luo Y, Guda K, Markowitz SD, Chak A, Kaz AM, Grady WM. Esophageal Cancer Biomarkers. In: Srivastava S, editor. Biomarkers in Cancer Screening and Early Detection. Chichester: John Wiley & Sons, Ltd; 2017. pp. 104-17. [DOI: 10.1002/9781118468869.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
80 Li X, Kleeman S, Coburn SB, Fumagalli C, Perner J, Jammula S, Pfeiffer RM, Orzolek L, Hao H, Taylor PR, Miremadi A, Galeano-Dalmau N, Lao-Sirieix P, Tennyson M, MacRae S, Cook MB, Fitzgerald RC. Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus. Gastroenterology. 2018;155:771-783.e3. [PMID: 29906417 DOI: 10.1053/j.gastro.2018.05.050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
81 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]